152 related articles for article (PubMed ID: 1599036)
1. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants".
Segal GH; Hart WR
Am J Surg Pathol; 1992 Jun; 16(6):577-83. PubMed ID: 1599036
[TBL] [Abstract][Full Text] [Related]
2. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
Kennedy AW; Hart WR
Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
[TBL] [Abstract][Full Text] [Related]
4. Ovarian serous borderline tumors with noninvasive and invasive peritoneal implants: A case report each.
Srinivasamurthy BC; Kulandai Velu AR; Krishnan N; Patil AS
J Cancer Res Ther; 2015; 11(3):646. PubMed ID: 26458602
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal serous micropapillomatosis of low malignant potential (serous borderline tumors of the peritoneum). A clinicopathologic study of 17 cases.
Biscotti CV; Hart WR
Am J Surg Pathol; 1992 May; 16(5):467-75. PubMed ID: 1599025
[TBL] [Abstract][Full Text] [Related]
6. Case Report: Borderline tumor and primary peritoneal carcinoma - a rare synchronism.
Rei M; Raposo S; Figueiredo P; Sousa R; Sá L
F1000Res; 2019; 8():1630. PubMed ID: 31807285
[TBL] [Abstract][Full Text] [Related]
7. Refined diagnostic criteria for implants associated with ovarian atypical proliferative serous tumors (borderline) and micropapillary serous carcinomas.
Bell KA; Smith Sehdev AE; Kurman RJ
Am J Surg Pathol; 2001 Apr; 25(4):419-32. PubMed ID: 11257616
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of peritoneal extensions for the diagnosis and management of serous ovarian borderline tumors].
Andrei S; Stolnicu S; Rădulescu D; Mocan S; Puşcaşu L
Rev Med Chir Soc Med Nat Iasi; 2006; 110(3):679-86. PubMed ID: 17571566
[TBL] [Abstract][Full Text] [Related]
9. Pathologic findings in eight cases of ovarian serous borderline tumors, three with foci of serous carcinoma, that preceded death or morbidity from invasive carcinoma.
Lee KR; Castrillon DH; Nucci MR
Int J Gynecol Pathol; 2001 Oct; 20(4):329-34. PubMed ID: 11603215
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants.
Cheng L; Wolf NG; Rose PG; Rodriguez M; Abdul-Karim FW
Acta Cytol; 1998; 42(5):1091-4. PubMed ID: 9755663
[TBL] [Abstract][Full Text] [Related]
11. [Peritoneal carcinomatosis].
Coelho SS; Silva PM; Ramos J
Acta Med Port; 1998 Jun; 11(6):585-9. PubMed ID: 9773541
[TBL] [Abstract][Full Text] [Related]
12. Serous psammocarcinoma of the ovary and peritoneum.
Gilks CB; Bell DA; Scully RE
Int J Gynecol Pathol; 1990; 9(2):110-21. PubMed ID: 2332269
[TBL] [Abstract][Full Text] [Related]
13. [Clinicopathologic analysis of ovarian serous and mucinous borderline tumors].
Zhong C; Yu X; Zhang J; Wei B; Luo B; Sun L; Zhang N; Fu Q
Zhonghua Bing Li Xue Za Zhi; 2001 Aug; 30(4):253-5. PubMed ID: 11758211
[TBL] [Abstract][Full Text] [Related]
14. Serous borderline tumors of the peritoneum.
Bell DA; Scully RE
Am J Surg Pathol; 1990 Mar; 14(3):230-9. PubMed ID: 2305929
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
[TBL] [Abstract][Full Text] [Related]
16. Ovarian serous borderline tumors with invasive peritoneal implants.
Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
[TBL] [Abstract][Full Text] [Related]
17. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators.
Seidman JD; Kurman RJ
Hum Pathol; 2000 May; 31(5):539-57. PubMed ID: 10836293
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
[TBL] [Abstract][Full Text] [Related]
19. Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.
Kane A; Uzan C; Rey A; Gouy S; Duvillard P; Morice P
Int J Gynecol Cancer; 2010 Apr; 20(3):346-52. PubMed ID: 20375795
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors and biomarkers in ovarian tumors development.
Vrabie CD; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
